• IPR MDR report
  • CHI whitepapers
  • ProServices
  • Clinical Informatics News
  • MDX Report

Drug Diagnostic Co-Development:
Biomarkers in Personalized Medicine


Drug Diagnostic Co-Development

Life Science Podcast

The New Paradigm of Data Intensive/Data Rich Protein Informatics
Eugene Kolker, Ph.D., Chief Data Officer, Center for Developmental Therapeutics, Children’s Hospital Seattle
Interview with Mary Ann Brown Click here to download


Life Science Media Library

Educational DVDs are one of many assets available from the Cambridge Healthtech Institute Life Science Media Library.

View and order all our DVDs and CDs at healthtech.com/cddvd


CHI News Releases


07.17.15 Prelim Agenda posted for PepTalk January 18-22, 2016


07.15.15 Prelim Agenda posted for FAST: Functional Analysis & Screening Technologies Congress November 9-11, 2015


07.15.15 Call for papers posted for Medical Informatics World April 4-5, 2016


07.14.15 Call for Papers posted for Biotherapeutics Analytical Summit March 14-18, 2016


07.13.15  Final Agenda posted for Reproductive Genetic Diagnostics November 18-19, 2015


More Conference Updates...

Careers
Available Positions:
Why work for CHI?
CONFERENCE PRODUCTION ASSISTANT
CONFERENCE PRODUCER, Diagnostics & Clinical Chemistry
CLIENT SERVICES SPECIALIST, sales team


Linkedin Twitter Xing Youtube

 


Conferences & Courses

Life Science Media Library

Conferences & Courses
Rapid Methods to Assess Quality & Stability of Biologics
August 3-4, 2015 | Boston, MA
The Bioprocessing Summit brings together international leaders to discuss today’s bioprocess issues from cell line selection to manufacturing.

Life Science Media Library
Physiochemical and Biophysical Characterization of ADC DVD
May 5, 2015 |
Antibody drug conjugates are complex, heterogeneous products that require a wide array of characterization tools to support manufacturing, storage and administration. It is critical to have meaningful analytical and biophysical tools early in development to rationally design the manufacturing process and to demonstrate control over the process and product. An effective analytical toolkit will enable the identification and elimination of liabilities, resulting in significant time and cost savings.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
Next Generation Dx Summit
August 18-20, 2015 | Washington, DC
The Seventh Annual Next Generation Dx Summit (August 18-20, 2015 in Washington, DC) encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer im

Life Science Media Library
Systems Biology, Synthesis in silico Discovery microRNA Biomarkers DVD
March 16, 2015 |
There currently exists no standard systematic way to identify candidate microRNAs for experimental evaluation and verification of their utility as disease biomarkers. In this course we will present a putative framework for the identification of candidate circulating microRNA biomarkers, based on in silico, systems biology and quantitative evidence synthesis techniques. We will discuss the implementation of circulating miRNA studies and examine relevant workflows, specimen collection and handling, quantification and data analysis techniques.
Reports
Liquid Biopsy: An Emerging Market for Radically Improved Cancer Mgmt
Liquid Biopsy: An Emerging Market for Radically Improved Cancer Management report explores the background, history and basic research of liquid biopsy covering the three sample categories that dominate liquid biopsy today: circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (EVs, also known as exosomes). This report also details the commercial aspects, market dynamics, and trends of liquid biopsy.

Conferences & Courses
Companion Diagnostics
August 18-19, 2015 | Washington, DC
The Seventh Annual Next Generation Dx Summit (August 18-20, 2015 in Washington, DC) encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer im

Life Science Media Library
Impact of Affordable Care Act and the Sunshine Act on Industry
February 4, 2013 |
In this DVD, we will discuss the new "sunshine provisions" in the Patient Protection and Affordable Health Care Act ("PPACA") and its implications and effects on clinical trial operations. Key topics to be addressed: Insurance coverage and strategies to improve clinical trial enrollment What is the Sunshine Act and what are the company’s legal requirements? Opportunities in the Biosimilars FDA rules and changes in operations What are first steps and strategies to become compliant with state and federal laws? How can companies maintain flexibility in dealing with evolving legislation? What business processes and systems are involved? Implementation struggles: Centralization of all payments; FMV process and standardization and the effect Change Management with Study teams: The balance of compliance and challenges of patient recruitment, site shortage

Conferences & Courses
The Bioprocessing Summit
August 3-7, 2015 | Boston, MA
The Bioprocessing Summit brings together international leaders to discuss today’s bioprocess issues from cell line selection to manufacturing.

Life Science Media Library
Production Challenges for Complex Biologics DVD
May 5, 2015 |
This course addresses the typical production issues encountered with complex biologics, namely fusion proteins, antibody-drug conjugates and bispecific antibodies. Experts elucidate the structure and nature of these biologics in order to understand and master their properties. Along with exploring manufacturing challenges, the course also reveals how to overcome these challenges with practical insights and advice.

Conferences & Courses
Discovery on Target
September 21-24, 2015 | Boston, MA
Cambridge Healthtech Institute will host its 13th Annual Discovery on Target event showcasing current and emerging “hot” targets for the pharmaceutical industry September 21-24, 2015 in Boston, MA.

Life Science Media Library
Trends in Physical Properties of Drugs
April 22, 2014 |
The physical properties of drugs influence all aspects of their discovery, development, formulation, and administration. They are key to efficacy, effective assays, and in vivo delivery. This course will discuss latest trends and state-of-the art of prediction and measurement of key properties. Properties important for enhanced efficacy, delivery, and formulation pKa, tautomerism, crystallization, others Computational prediction: What works - what doesn’t Experimental best practices
Reports
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses
GPCR-Based Drug Discovery Part 1
September 22-23, 2015 | Boston, MA
Despite their fruitful history in the drug development industry, discovering or designing new therapeutic agents that modulate a GPCR in a specific way is still a challenge, and in fact is undergoing a renewal because of explosion of new knowledge about t

Life Science Media Library
Clinical Trial Monitoring and Compliance
February 4, 2013 |
In this DVD, we will discuss the ever-changing role of the CRA and explore ways in which this relationship can be leveraged to maximize productivity with study sites. Key topics to be addressed: How to build and maintain the relationship between sponsor and site Ways to partner with your sites during different phases of clinical trials How to have an enrollment discussion with your site; define mutual goals and expectations How to ensure ROI on territory development activities
Reports
Vaccines: The End of Illness
This report analyzes recent trends in medicinal chemistry and evaluates their significance for advancing R&D productivity. We consider technological modalities and market dynamics, with an emphasis on outsourcing and user views on the implications of current practices.

Conferences & Courses
Extractables and Leachables
January 21-22, 2016 | San Diego, CA
Cambridge Healthtech Institute' s Second Annual Extractables and Leachables conference focuses in biopharmaceutical drug development and manufacturing, containers, drug delivery devices/combination products (inhalers, pens, insulin pumps and implants), an

Life Science Media Library
Strategies for Protein Purification and Overcoming Aggregation
January 20, 2013 |
Together with input from Sarah Bondos from Texas A&M University, Mario Lebendiker of the Wolfson Centre for Applied Structural Biology at The Hebrew University of Jerusalem provides an indepth overview of protein purification with a particular focus on aggregation problems. This course reviews: common causes of protein aggregation during expression and purification, methods to detect the presence of aggregates, the types and properties of chemicals that, when added to buffers, may improve protein solubility, and methods to screen these additives to rapidly optimize the solubility of your protein.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
IMVACS-The Immunotherapies & Vaccine Summit
August 24-28, 2015 | Boston, MA
The Clinical Genome Conference, June 22-24, 2015 The unstoppable march of genomics into clinical practice continues.

Life Science Media Library
Trends in Physical Properties of Drugs
April 22, 2014 |
The physical properties of drugs influence all aspects of their discovery, development, formulation, and administration. They are key to efficacy, effective assays, and in vivo delivery. This course will discuss latest trends and state-of-the art of prediction and measurement of key properties. Properties important for enhanced efficacy, delivery, and formulation pKa, tautomerism, crystallization, others Computational prediction: What works - what doesn’t Experimental best practices
Reports
Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria
Antibiotic Renaissance: Technology and Market Advances in the War against Drug-resistant Bacteria covers evolutionary growth of antibiotic resistant bacteria with a focus in research aspects, commercial aspects, market aspects, and trends in antibiotic resistance.

Conferences & Courses
Discovery on Target
September 21-24, 2015 | Boston, MA
Cambridge Healthtech Institute will host its 13th Annual Discovery on Target event showcasing current and emerging “hot” targets for the pharmaceutical industry September 21-24, 2015 in Boston, MA.

Life Science Media Library
Introduction to Adoptive T Cell Therapies DVD
May 5, 2014 |
Adoptive T cell therapy has the potential to increase antitumor immunity, enhance vaccine efficacy, and limit graft-versus-host disease (GVHD). Recent advances in protein engineering and molecular biology have increased the feasibility of using genetically engineered T cells to treat disease, leading to an influx of new discoveries and techniques. This course DVD will educate viewers on the basic rules of adoptive T cell therapies before delving into strategies for developing chimeric antigen receptors (CARs) and T cell receptors (TCRs).

Conferences & Courses
NGS Diagnostics
August 19-20, 2015 | Washington, DC
The Seventh Annual Next Generation Dx Summit (August 18-20, 2015 in Washington, DC) encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer im

Life Science Media Library
Next Generation Sequencing
August 14, 2012 |
If you are confused by the evolving, rapidly changing, and dynamic nature of the Next Generation Sequencing market, then this is the course for you. This course will provide you with a comprehensive, clear outline of the various sequencing technologies currently available, their best suited applications, and which analysis strategies go with what applications in order to get the best answer from the data.
Reports
Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor
New to insight Pharma Reports is Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor. This report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare.

Conferences & Courses
Coverage and Reimbursement of Advanced Diagnostics
August 18-19, 2015 | Washington, DC
The Seventh Annual Next Generation Dx Summit (August 18-20, 2015 in Washington, DC) encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer im

Life Science Media Library
Clinical Genome Sequencing
June 11, 2012 |
The move to push genome sequencing into routine clinical practice requires arguably as much skill in navigating bureaucracy as mapping and interpreting base pairs. This short course provides practical information on crafting clinical sequencing and analysis pipeline strategies while navigating the route of CAP and CLIA certification by those who have sailed through these uncharted waters.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
Converged IT Summit 2015
September 9-10, 2015 | San Francisco, CA
The Converged IT Summit is designed for professionals involved with strategic planning and implementation of IT technologies to support science.

Life Science Media Library
IT Project Planning and Implementation
April 9, 2013 |
Key topics to be addressed: This session is designed to help the project team to understand and create a project plan for the delivery of the project to the portfolio; To provide assistance to project teams in the delivery of the Significant and high visible projects to portfolio where success is critical to both the team and the organization The success of any project depends on the planning activities especially delivery

Conferences & Courses
Enabling Point-of-Care Diagnostics
August 18-19, 2015 | Washington, DC
The Seventh Annual Next Generation Dx Summit (August 18-20, 2015 in Washington, DC) encompasses predictive cancer biomarkers, companion diagnostics, infectious disease, point-of-care, pharmacy-based diagnostics, cell-free DNA, commercialization, cancer im

Life Science Media Library
Converged IT Infrastructure in Life Science DVD
April 21, 2015 |
This all-BioTeam workshop will focus on covering the entire array of best practices for converged infrastructure through hardware selection, configuration, software, and data management for life sciences research and clinical environments. BioTeam defines converged infrastructure as the unification of disparate hardware, software, and support personnel into a blended and tuned end-to-end solution that makes it easier for scientists and clinicians to accomplish their data interpretation goals. The agenda of the workshop will focus on presenting and discussing reference designs for networking, storage, HPC, cloud (public and private), and hybrid infrastructures, as well as scientific software installation, maintenance, and development best practices. The course is designed to inform IT organizations and tech-savvy scientists about the methodologies and best practices behind making the datacenter an extension of the laboratory in a manner that enables scientific discovery, rather than forcing science to adapt to IT infrastructure. This intensive 3 ½ hour course will leave you with many ideas for how to better support the scientists and clinicians within your organization.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

Conferences & Courses
Immunomodulatory Therapeutic Antibodies for Cancer
August 24-25, 2015 | Boston, MA
The Clinical Genome Conference, June 22-24, 2015 The unstoppable march of genomics into clinical practice continues.

Life Science Media Library
Understanding EMT: Mechanisms and Metastasis to MET
February 20, 2012 |
Epethelial Mesenchymal Transition (EMT) plays a critical role in cancer cells, but understanding of its mechanisms is incomplete. EMT causes cells to develop increased motility, invasiveness, and greater resistance to apoptosis. These changes make the cells more like stem cells, allowing them to self renew. This course provides a framework of the underlying molecular mechanisms while addressing stem cells, and cancer progression, cMET and their activity as anti-metastasis agents, and the Mesenchymal-Epethelial Transition (MET) as an essential process for tumor re-initiation, colonization, and metastasis.
Reports
Ocular Disorders: Rising Therapeutics, Technologies, and Devices
New to Insight Pharma Reports is: Ocular Disorders: Rising Therapeutics, Technologies, and Devices. This report covers several companies and their approach to targeting ocular diseases including wet and dry age-related macular degeneration (AMD) while also providing alternative therapeutic options for various ocular complications.

ABOUT CHI


CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Cambridge Marketing Consultants, Barnett Educational Services, Cambridge Meeting Planners and CHI’s Media Group, which includes news websites and e-newsletters including Bio-IT World and Clinical Informatics News.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.


CONFERENCES 


REPORTS 


BARNETT EDUCATIONAL SERVICES 


CONSULTING 


PUBLICATIONS & eNEWSLETTERS 


PROFESSIONAL SERVICES 


KNOWLEDGE FOUNDATION 


EXECUTIVE TEAM 


CAREERS